+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Tubeless Insulin Pumps Market - Global Forecast 2026-2032

  • Report

  • 189 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6126880
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Tubeless Insulin Pumps Market is projected to reach USD 1.52 Billion in 2026. It is expected to continue growing at a CAGR of 12.96%, reaching USD 3.25 Billion by 2032.

Tubeless Insulin Pumps: Executive Summary

Tubeless insulin pumps are wearable insulin-delivery systems designed to provide programmable subcutaneous insulin without the tubing used in conventional pumps. Their value proposition centers on greater freedom of movement, discreet wear, automated dosing capabilities, and integration with glucose-monitoring technologies. Adoption is shaped by clinical suitability, reimbursement, device usability, training requirements, supply continuity, and confidence in digital connectivity.

Tubeless Delivery Is Reshaping Diabetes-Management Workflows

The landscape is shifting from standalone delivery devices toward connected, data-informed care ecosystems. Product development increasingly emphasizes smaller form factors, simplified insertion, extended wear, smartphone-based control, interoperability with continuous glucose monitoring, and automated insulin-delivery functionality. These changes are also altering responsibilities across patients, caregivers, clinicians, diabetes educators, pharmacies, and remote-care teams. Persistent barriers include device cost, eligibility criteria, skin and adhesion concerns, alarm fatigue, cybersecurity expectations, and the need for reliable technical support.

Artificial Intelligence Strengthens Personalization, Not Clinical Accountability

Artificial intelligence can enhance tubeless pump ecosystems by identifying glucose patterns, supporting insulin-dose recommendations, detecting likely infusion or adherence problems, and prioritizing data for clinical review. Machine-learning tools may also help personalize alerts and reduce unnecessary intervention. However, safe deployment depends on representative training data, transparent performance evaluation, robust cybersecurity, human oversight, and clear accountability when recommendations are wrong or data are incomplete. AI should support-not replace-clinical judgment and patient education.

Regional Differences Reflect Access, Regulation, and Care Infrastructure

North America is characterized by comparatively strong digital-health infrastructure and active integration between pumps, glucose sensors, and remote monitoring, while affordability and reimbursement remain important determinants of access. Europe combines sophisticated diabetes services with varied national reimbursement, procurement, and regulatory pathways across the region. Asia-Pacific includes advanced technology markets alongside highly diverse healthcare capacity, creating differing adoption conditions. Latin America faces uneven reimbursement, specialist availability, and distribution coverage. Middle East adoption is influenced by investment in modern diabetes services, local procurement, and workforce capability. Africa generally requires solutions that address affordability, supply reliability, training, and limited specialist access. Across all regions, localization, education, and dependable consumables are as important as device functionality.

Group-Level Priorities Differ Across ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN markets require adaptable affordability and distribution strategies because healthcare financing and diabetes-service maturity vary substantially among members. BRICS countries combine large and diverse patient populations with differing domestic manufacturing, reimbursement, and regulatory environments. The European Union places strong emphasis on medical-device compliance, data protection, interoperability, and country-level reimbursement decisions. G7 systems generally have advanced clinical infrastructure but continue to evaluate cost-effectiveness, equitable access, and integration into established care pathways. GCC countries benefit from concentrated healthcare investment while needing workforce development and sustainable procurement models. NATO members span varied health systems, so shared security and resilience concerns do not eliminate national differences in reimbursement, procurement, or clinical practice.

Country Insights Highlight Distinct Adoption Conditions

Australia’s organized diabetes services and remote-care capabilities support connected device use, subject to reimbursement and geographic access. Brazil and Mexico must navigate regional disparities, affordability, and specialist availability. Canada’s public and private coverage arrangements vary by jurisdiction. China combines expanding digital-health capabilities with complex regulatory and provincial access conditions. France, Germany, Italy, and Spain operate within European regulatory structures but differ in reimbursement, procurement, and clinical pathways. India’s opportunity is accompanied by substantial affordability, training, and distribution challenges. Japan emphasizes usability, reliability, and integration with established clinical workflows. Russia’s access environment is influenced by local supply, regulation, and healthcare-system conditions. South Korea has advanced digital connectivity but remains sensitive to reimbursement and clinical adoption policies. The United Kingdom’s uptake depends on national guidance, commissioning, and service capacity. The United States has broad technology availability and specialized care networks, while coverage complexity, out-of-pocket costs, and health-equity considerations remain central.

Industry Leaders Should Prioritize Interoperability, Access, and Trust

Leaders should design tubeless pump platforms around interoperable data exchange, intuitive onboarding, dependable adhesion and consumable supply, and clear failure-response procedures. Evidence generation should address real-world outcomes, quality of life, persistence, safety, and performance across age groups and care settings. Market access plans should align clinical evidence with country-specific reimbursement requirements and include affordability programs where appropriate. Organizations should strengthen cybersecurity, privacy controls, software lifecycle governance, and human oversight of AI-enabled functions. Partnerships with clinicians, educators, patient communities, payers, and distribution networks can improve implementation, while multilingual training and accessible support can reduce avoidable discontinuation.

Research Methodology for the Tubeless Insulin Pump Assessment

This executive summary is based on a structured review framework for tubeless insulin pumps, covering device characteristics, connected-care functionality, clinical workflows, regulatory considerations, reimbursement, infrastructure, patient experience, and regional access conditions. Geographic analysis incorporates North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific, with additional consideration of the specified country and group lenses. Findings are synthesized from publicly verifiable sources such as regulatory materials, clinical and health-services literature, government publications, professional guidance, and documented technology information. Qualitative conclusions are separated from quantitative claims, and no market estimates, shares, forecasts, or unsupported company-specific assertions are used.

Tubeless Pumps Will Advance Through Evidence-Based, Connected Care

Tubeless insulin pumps are positioned within a broader transition toward personalized, digitally connected diabetes management. Their sustained contribution will depend less on hardware novelty alone than on safety, interoperability, affordability, clinical support, and reliable access to supplies and data. Artificial intelligence can improve personalization when governed responsibly, while regional and country-level implementation must reflect local health-system realities. Leaders that combine robust evidence with inclusive design, resilient operations, and transparent patient support will be best placed to improve adoption and outcomes.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Tubeless Insulin Pumps Market, by Type Of Diabetes
7.1. Introduction
7.2. Type 1 Diabetes
7.3. Type 2 Diabetes
8. Tubeless Insulin Pumps Market, by Connectivity
8.1. Introduction
8.2. Bluetooth
8.3. Cellular
9. Tubeless Insulin Pumps Market, by Sensor Wear Duration
9.1. Introduction
9.2. Fourteen Day
9.3. Seven Day
10. Tubeless Insulin Pumps Market, by Price Range
10.1. Introduction
10.2. Economy
10.3. Mid Range
10.4. Premium
11. Tubeless Insulin Pumps Market, by Technology Generation
11.1. Introduction
11.2. First Generation
11.3. Second Generation
12. Tubeless Insulin Pumps Market, by End User
12.1. Introduction
12.2. Adults
12.3. Pediatrics
13. Tubeless Insulin Pumps Market, by Distribution Channel
13.1. Introduction
13.2. Online
13.3. Offline
14. Tubeless Insulin Pumps Market, by Region
14.1. Introduction
14.2. Asia-Pacific
14.3. North America
14.4. Latin America
14.5. Europe
14.6. Middle East
14.7. Africa
15. Tubeless Insulin Pumps Market, by Group
15.1. Introduction
15.2. ASEAN
15.3. GCC
15.4. European Union
15.5. BRICS
15.6. G7
15.7. NATO
16. Tubeless Insulin Pumps Market, by Country
16.1. Introduction
16.2. United States
16.3. Canada
16.4. Mexico
16.5. Brazil
16.6. United Kingdom
16.7. Germany
16.8. France
16.9. Russia
16.10. Italy
16.11. Spain
16.12. China
16.13. India
16.14. Japan
16.15. Australia
16.16. South Korea
17. Competitive Landscape
17.1. Market Share Analysis, 2025
17.2. Market Concentration Analysis, 2025
17.2.1. Concentration Ratio (CR)
17.2.2. Herfindahl Hirschman Index (HHI)
17.3. Recent Developments & Impact Analysis, 2025
17.4. Product Portfolio Analysis, 2025
17.5. Benchmarking Analysis, 2025
18. Company Profiles
18.1. Abbott Laboratories
18.2. Advanced Microfluidics SA
18.3. APEX Medical Devices
18.4. Ascensia Diabetes Care
18.5. Beta Bionics, Inc.
18.6. Bigfoot Biomedical, Inc.
18.7. Cam Med LLC
18.8. CareMedi Co., Ltd.
18.9. Cellnovo Group plc
18.10. CeQur Corporation
18.11. Debiotech S.A.
18.12. Diabeloop SAS
18.13. EOFlow Co., Ltd.
18.14. F. Hoffmann-La Roche Ltd.
18.15. Insulet Corporation
18.16. Johnson & Johnson
18.17. Luna Health Inc.
18.18. Medipacs Inc.
18.19. Medtrum Technologies Inc.
18.20. MicroPort Scientific Corporation
18.21. Modular Medical, Inc.
18.22. PharmaSens AG
18.23. Tandem Diabetes Care, Inc.
18.24. Terumo Corporation
18.25. Valeritas Holdings, Inc.
18.26. ViCentra B.V.
18.27. Ypsomed AG
19. Key Experts
LIST OF FIGURES
FIGURE 1. Global Tubeless Insulin Pumps Market, Years Considered for the Study
FIGURE 2. Global Tubeless Insulin Pumps Market, Research Design
FIGURE 3. Global Tubeless Insulin Pumps Market, Research Framework
FIGURE 4. Global Tubeless Insulin Pumps Market, Data Triangulation
FIGURE 5. Global Tubeless Insulin Pumps Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Tubeless Insulin Pumps Market Size, by Type Of Diabetes, 2025 vs 2032 (%)
FIGURE 7. Global Tubeless Insulin Pumps Market Size, by Type Of Diabetes, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Tubeless Insulin Pumps Market Size, by Connectivity, 2025 vs 2032 (%)
FIGURE 9. Global Tubeless Insulin Pumps Market Size, by Connectivity, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Tubeless Insulin Pumps Market Size, by Sensor Wear Duration, 2025 vs 2032 (%)
FIGURE 11. Global Tubeless Insulin Pumps Market Size, by Sensor Wear Duration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Tubeless Insulin Pumps Market Size, by Price Range, 2025 vs 2032 (%)
FIGURE 13. Global Tubeless Insulin Pumps Market Size, by Price Range, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Tubeless Insulin Pumps Market Size, by Technology Generation, 2025 vs 2032 (%)
FIGURE 15. Global Tubeless Insulin Pumps Market Size, by Technology Generation, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Tubeless Insulin Pumps Market Size, by End User, 2025 vs 2032 (%)
FIGURE 17. Global Tubeless Insulin Pumps Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Tubeless Insulin Pumps Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 19. Global Tubeless Insulin Pumps Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Tubeless Insulin Pumps Market Size, by Region, 2025 vs 2032 (%)
FIGURE 21. Global Tubeless Insulin Pumps Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 22. Global Tubeless Insulin Pumps Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Tubeless Insulin Pumps Market Size, by Country, 2025 vs 2032 (%)
FIGURE 24. Global Tubeless Insulin Pumps Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 25. Global Tubeless Insulin Pumps Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Tubeless Insulin Pumps Market Segmentation & Coverage
TABLE 2. Global Tubeless Insulin Pumps Market Size, 2017-2032 (USD Million)
TABLE 3. Global Tubeless Insulin Pumps Market Size, by Type Of Diabetes, 2017-2032 (USD Million)
TABLE 4. Global Type 1 Diabetes Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Type 1 Diabetes Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Type 1 Diabetes Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Type 2 Diabetes Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Type 2 Diabetes Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Type 2 Diabetes Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Tubeless Insulin Pumps Market Size, by Connectivity, 2017-2032 (USD Million)
TABLE 11. Global Bluetooth Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Bluetooth Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Bluetooth Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Cellular Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Cellular Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Cellular Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Tubeless Insulin Pumps Market Size, by Sensor Wear Duration, 2017-2032 (USD Million)
TABLE 18. Global Fourteen Day Market Size, by Region, 2017-2032 (USD Million)
TABLE 19. Global Fourteen Day Market Size, by Group, 2017-2032 (USD Million)
TABLE 20. Global Fourteen Day Market Size, by Country, 2017-2032 (USD Million)
TABLE 21. Global Seven Day Market Size, by Region, 2017-2032 (USD Million)
TABLE 22. Global Seven Day Market Size, by Group, 2017-2032 (USD Million)
TABLE 23. Global Seven Day Market Size, by Country, 2017-2032 (USD Million)
TABLE 24. Global Tubeless Insulin Pumps Market Size, by Price Range, 2017-2032 (USD Million)
TABLE 25. Global Economy Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Economy Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Economy Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Mid Range Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Mid Range Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Mid Range Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Premium Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Premium Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Premium Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Tubeless Insulin Pumps Market Size, by Technology Generation, 2017-2032 (USD Million)
TABLE 35. Global First Generation Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global First Generation Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global First Generation Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Second Generation Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Second Generation Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Second Generation Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Tubeless Insulin Pumps Market Size, by End User, 2017-2032 (USD Million)
TABLE 42. Global Adults Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Adults Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Adults Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Pediatrics Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Pediatrics Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Pediatrics Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Tubeless Insulin Pumps Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 49. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Tubeless Insulin Pumps Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Asia-Pacific Tubeless Insulin Pumps Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Asia-Pacific Tubeless Insulin Pumps Market Size, by Type Of Diabetes, 2017-2032 (USD Million)
TABLE 58. Asia-Pacific Tubeless Insulin Pumps Market Size, by Connectivity, 2017-2032 (USD Million)
TABLE 59. Asia-Pacific Tubeless Insulin Pumps Market Size, by Sensor Wear Duration, 2017-2032 (USD Million)
TABLE 60. Asia-Pacific Tubeless Insulin Pumps Market Size, by Price Range, 2017-2032 (USD Million)
TABLE 61. Asia-Pacific Tubeless Insulin Pumps Market Size, by Technology Generation, 2017-2032 (USD Million)
TABLE 62. Asia-Pacific Tubeless Insulin Pumps Market Size, by End User, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Tubeless Insulin Pumps Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 64. North America Tubeless Insulin Pumps Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. North America Tubeless Insulin Pumps Market Size, by Type Of Diabetes, 2017-2032 (USD Million)
TABLE 66. North America Tubeless Insulin Pumps Market Size, by Connectivity, 2017-2032 (USD Million)
TABLE 67. North America Tubeless Insulin Pumps Market Size, by Sensor Wear Duration, 2017-2032 (USD Million)
TABLE 68. North America Tubeless Insulin Pumps Market Size, by Price Range, 2017-2032 (USD Million)
TABLE 69. North America Tubeless Insulin Pumps Market Size, by Technology Generation, 2017-2032 (USD Million)
TABLE 70. North America Tubeless Insulin Pumps Market Size, by End User, 2017-2032 (USD Million)
TABLE 71. North America Tubeless Insulin Pumps Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 72. Latin America Tubeless Insulin Pumps Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Latin America Tubeless Insulin Pumps Market Size, by Type Of Diabetes, 2017-2032 (USD Million)
TABLE 74. Latin America Tubeless Insulin Pumps Market Size, by Connectivity, 2017-2032 (USD Million)
TABLE 75. Latin America Tubeless Insulin Pumps Market Size, by Sensor Wear Duration, 2017-2032 (USD Million)
TABLE 76. Latin America Tubeless Insulin Pumps Market Size, by Price Range, 2017-2032 (USD Million)
TABLE 77. Latin America Tubeless Insulin Pumps Market Size, by Technology Generation, 2017-2032 (USD Million)
TABLE 78. Latin America Tubeless Insulin Pumps Market Size, by End User, 2017-2032 (USD Million)
TABLE 79. Latin America Tubeless Insulin Pumps Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 80. Europe Tubeless Insulin Pumps Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Europe Tubeless Insulin Pumps Market Size, by Type Of Diabetes, 2017-2032 (USD Million)
TABLE 82. Europe Tubeless Insulin Pumps Market Size, by Connectivity, 2017-2032 (USD Million)
TABLE 83. Europe Tubeless Insulin Pumps Market Size, by Sensor Wear Duration, 2017-2032 (USD Million)
TABLE 84. Europe Tubeless Insulin Pumps Market Size, by Price Range, 2017-2032 (USD Million)
TABLE 85. Europe Tubeless Insulin Pumps Market Size, by Technology Generation, 2017-2032 (USD Million)
TABLE 86. Europe Tubeless Insulin Pumps Market Size, by End User, 2017-2032 (USD Million)
TABLE 87. Europe Tubeless Insulin Pumps Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 88. Middle East Tubeless Insulin Pumps Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Middle East Tubeless Insulin Pumps Market Size, by Type Of Diabetes, 2017-2032 (USD Million)
TABLE 90. Middle East Tubeless Insulin Pumps Market Size, by Connectivity, 2017-2032 (USD Million)
TABLE 91. Middle East Tubeless Insulin Pumps Market Size, by Sensor Wear Duration, 2017-2032 (USD Million)
TABLE 92. Middle East Tubeless Insulin Pumps Market Size, by Price Range, 2017-2032 (USD Million)
TABLE 93. Middle East Tubeless Insulin Pumps Market Size, by Technology Generation, 2017-2032 (USD Million)
TABLE 94. Middle East Tubeless Insulin Pumps Market Size, by End User, 2017-2032 (USD Million)
TABLE 95. Middle East Tubeless Insulin Pumps Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 96. Africa Tubeless Insulin Pumps Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Africa Tubeless Insulin Pumps Market Size, by Type Of Diabetes, 2017-2032 (USD Million)
TABLE 98. Africa Tubeless Insulin Pumps Market Size, by Connectivity, 2017-2032 (USD Million)
TABLE 99. Africa Tubeless Insulin Pumps Market Size, by Sensor Wear Duration, 2017-2032 (USD Million)
TABLE 100. Africa Tubeless Insulin Pumps Market Size, by Price Range, 2017-2032 (USD Million)
TABLE 101. Africa Tubeless Insulin Pumps Market Size, by Technology Generation, 2017-2032 (USD Million)
TABLE 102. Africa Tubeless Insulin Pumps Market Size, by End User, 2017-2032 (USD Million)
TABLE 103. Africa Tubeless Insulin Pumps Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 104. Global Tubeless Insulin Pumps Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. ASEAN Tubeless Insulin Pumps Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. ASEAN Tubeless Insulin Pumps Market Size, by Type Of Diabetes, 2017-2032 (USD Million)
TABLE 107. ASEAN Tubeless Insulin Pumps Market Size, by Connectivity, 2017-2032 (USD Million)
TABLE 108. ASEAN Tubeless Insulin Pumps Market Size, by Sensor Wear Duration, 2017-2032 (USD Million)
TABLE 109. ASEAN Tubeless Insulin Pumps Market Size, by Price Range, 2017-2032 (USD Million)
TABLE 110. ASEAN Tubeless Insulin Pumps Market Size, by Technology Generation, 2017-2032 (USD Million)
TABLE 111. ASEAN Tubeless Insulin Pumps Market Size, by End User, 2017-2032 (USD Million)
TABLE 112. ASEAN Tubeless Insulin Pumps Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 113. GCC Tubeless Insulin Pumps Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. GCC Tubeless Insulin Pumps Market Size, by Type Of Diabetes, 2017-2032 (USD Million)
TABLE 115. GCC Tubeless Insulin Pumps Market Size, by Connectivity, 2017-2032 (USD Million)
TABLE 116. GCC Tubeless Insulin Pumps Market Size, by Sensor Wear Duration, 2017-2032 (USD Million)
TABLE 117. GCC Tubeless Insulin Pumps Market Size, by Price Range, 2017-2032 (USD Million)
TABLE 118. GCC Tubeless Insulin Pumps Market Size, by Technology Generation, 2017-2032 (USD Million)
TABLE 119. GCC Tubeless Insulin Pumps Market Size, by End User, 2017-2032 (USD Million)
TABLE 120. GCC Tubeless Insulin Pumps Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 121. European Union Tubeless Insulin Pumps Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. European Union Tubeless Insulin Pumps Market Size, by Type Of Diabetes, 2017-2032 (USD Million)
TABLE 123. European Union Tubeless Insulin Pumps Market Size, by Connectivity, 2017-2032 (USD Million)
TABLE 124. European Union Tubeless Insulin Pumps Market Size, by Sensor Wear Duration, 2017-2032 (USD Million)
TABLE 125. European Union Tubeless Insulin Pumps Market Size, by Price Range, 2017-2032 (USD Million)
TABLE 126. European Union Tubeless Insulin Pumps Market Size, by Technology Generation, 2017-2032 (USD Million)
TABLE 127. European Union Tubeless Insulin Pumps Market Size, by End User, 2017-2032 (USD Million)
TABLE 128. European Union Tubeless Insulin Pumps Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 129. BRICS Tubeless Insulin Pumps Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. BRICS Tubeless Insulin Pumps Market Size, by Type Of Diabetes, 2017-2032 (USD Million)
TABLE 131. BRICS Tubeless Insulin Pumps Market Size, by Connectivity, 2017-2032 (USD Million)
TABLE 132. BRICS Tubeless Insulin Pumps Market Size, by Sensor Wear Duration, 2017-2032 (USD Million)
TABLE 133. BRICS Tubeless Insulin Pumps Market Size, by Price Range, 2017-2032 (USD Million)
TABLE 134. BRICS Tubeless Insulin Pumps Market Size, by Technology Generation, 2017-2032 (USD Million)
TABLE 135. BRICS Tubeless Insulin Pumps Market Size, by End User, 2017-2032 (USD Million)
TABLE 136. BRICS Tubeless Insulin Pumps Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 137. G7 Tubeless Insulin Pumps Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. G7 Tubeless Insulin Pumps Market Size, by Type Of Diabetes, 2017-2032 (USD Million)
TABLE 139. G7 Tubeless Insulin Pumps Market Size, by Connectivity, 2017-2032 (USD Million)
TABLE 140. G7 Tubeless Insulin Pumps Market Size, by Sensor Wear Duration, 2017-2032 (USD Million)
TABLE 141. G7 Tubeless Insulin Pumps Market Size, by Price Range, 2017-2032 (USD Million)
TABLE 142. G7 Tubeless Insulin Pumps Market Size, by Technology Generation, 2017-2032 (USD Million)
TABLE 143. G7 Tubeless Insulin Pumps Market Size, by End User, 2017-2032 (USD Million)
TABLE 144. G7 Tubeless Insulin Pumps Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 145. NATO Tubeless Insulin Pumps Market Size, by Group, 2017-2032 (USD Million)
TABLE 146. NATO Tubeless Insulin Pumps Market Size, by Type Of Diabetes, 2017-2032 (USD Million)
TABLE 147. NATO Tubeless Insulin Pumps Market Size, by Connectivity, 2017-2032 (USD Million)
TABLE 148. NATO Tubeless Insulin Pumps Market Size, by Sensor Wear Duration, 2017-2032 (USD Million)
TABLE 149. NATO Tubeless Insulin Pumps Market Size, by Price Range, 2017-2032 (USD Million)
TABLE 150. NATO Tubeless Insulin Pumps Market Size, by Technology Generation, 2017-2032 (USD Million)
TABLE 151. NATO Tubeless Insulin Pumps Market Size, by End User, 2017-2032 (USD Million)
TABLE 152. NATO Tubeless Insulin Pumps Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 153. Global Tubeless Insulin Pumps Market Size, by Country, 2017-2032 (USD Million)
TABLE 154. United States Tubeless Insulin Pumps Market Size, 2017-2032 (USD Million)
TABLE 155. United States Tubeless Insulin Pumps Market Size, by Type Of Diabetes, 2017-2032 (USD Million)
TABLE 156. United States Tubeless Insulin Pumps Market Size, by Connectivity, 2017-2032 (USD Million)
TABLE 157. United States Tubeless Insulin Pumps Market Size, by Sensor Wear Duration, 2017-2032 (USD Million)
TABLE 158. United States Tubeless Insulin Pumps Market Size, by Price Range, 2017-2032 (USD Million)
TABLE 159. United States Tubeless Insulin Pumps Market Size, by Technology Generation, 2017-2032 (USD Million)
TABLE 160. United States Tubeless Insulin Pumps Market Size, by End User, 2017-2032 (USD Million)
TABLE 161. United States Tubeless Insulin Pumps Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 162. Canada Tubeless Insulin Pumps Market Size, 2017-2032 (USD Million)
TABLE 163. Canada Tubeless Insulin Pumps Market Size, by Type Of Diabetes, 2017-2032 (USD Million)
TABLE 164. Canada Tubeless Insulin Pumps Market Size, by Connectivity, 2017-2032 (USD Million)
TABLE 165. Canada Tubeless Insulin Pumps Market Size, by Sensor Wear Duration, 2017-2032 (USD Million)
TABLE 166. Canada Tubeless Insulin Pumps Market Size, by Price Range, 2017-2032 (USD Million)
TABLE 167. Canada Tubeless Insulin Pumps Market Size, by Technology Generation, 2017-2032 (USD Million)
TABLE 168. Canada Tubeless Insulin Pumps Market Size, by End User, 2017-2032 (USD Million)
TABLE 169. Canada Tubeless Insulin Pumps Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 170. Mexico Tubeless Insulin Pumps Market Size, 2017-2032 (USD Million)
TABLE 171. Mexico Tubeless Insulin Pumps Market Size, by Type Of Diabetes, 2017-2032 (USD Million)
TABLE 172. Mexico Tubeless Insulin Pumps Market Size, by Connectivity, 2017-2032 (USD Million)
TABLE 173. Mexico Tubeless Insulin Pumps Market Size, by Sensor Wear Duration, 2017-2032 (USD Million)
TABLE 174. Mexico Tubeless Insulin Pumps Market Size, by Price Range, 2017-2032 (USD Million)
TABLE 175. Mexico Tubeless Insulin Pumps Market Size, by Technology Generation, 2017-2032 (USD Million)
TABLE 176. Mexico Tubeless Insulin Pumps Market Size, by End User, 2017-2032 (USD Million)
TABLE 177. Mexico Tubeless Insulin Pumps Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 178. Brazil Tubeless Insulin Pumps Market Size, 2017-2032 (USD Million)
TABLE 179. Brazil Tubeless Insulin Pumps Market Size, by Type Of Diabetes, 2017-2032 (USD Million)
TABLE 180. Brazil Tubeless Insulin Pumps Market Size, by Connectivity, 2017-2032 (USD Million)
TABLE 181. Brazil Tubeless Insulin Pumps Market Size, by Sensor Wear Duration, 2017-2032 (USD Million)
TABLE 182. Brazil Tubeless Insulin Pumps Market Size, by Price Range, 2017-2032 (USD Million)
TABLE 183. Brazil Tubeless Insulin Pumps Market Size, by Technology Generation, 2017-2032 (USD Million)
TABLE 184. Brazil Tubeless Insulin Pumps Market Size, by End User, 2017-2032 (USD Million)
TABLE 185. Brazil Tubeless Insulin Pumps Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 186. United Kingdom Tubeless Insulin Pumps Market Size, 2017-2032 (USD Million)
TABLE 187. United Kingdom Tubeless Insulin Pumps Market Size, by Type Of Diabetes, 2017-2032 (USD Million)
TABLE 188. United Kingdom Tubeless Insulin Pumps Market Size, by Connectivity, 2017-2032 (USD Million)
TABLE 189. United Kingdom Tubeless Insulin Pumps Market Size, by Sensor Wear Duration, 2017-2032 (USD Million)
TABLE 190. United Kingdom Tubeless Insulin Pumps Market Size, by Price Range, 2017-2032 (USD Million)
TABLE 191. United Kingdom Tubeless Insulin Pumps Market Size, by Technology Generation, 2017-2032 (USD Million)
TABLE 192. United Kingdom Tubeless Insulin Pumps Market Size, by End User, 2017-2032 (USD Million)
TABLE 193. United Kingdom Tubeless Insulin Pumps Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 194. Germany Tubeless Insulin Pumps Market Size, 2017-2032 (USD Million)
TABLE 195. Germany Tubeless Insulin Pumps Market Size, by Type Of Diabetes, 2017-2032 (USD Million)
TABLE 196. Germany Tubeless Insulin Pumps Market Size, by Connectivity, 2017-2032 (USD Million)
TABLE 197. Germany Tubeless Insulin Pumps Market Size, by Sensor Wear Duration, 2017-2032 (USD Million)
TABLE 198. Germany Tubeless Insulin Pumps Market Size, by Price Range, 2017-2032 (USD Million)
TABLE 199. Germany Tubeless Insulin Pumps Market Size, by Technology Generation, 2017-2032 (USD Million)
TABLE 200. Germany Tubeless Insulin Pumps Market Size, by End User, 2017-2032 (USD Million)
TABLE 201. Germany Tubeless Insulin Pumps Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 202. France Tubeless Insulin Pumps Market Size, 2017-2032 (USD Million)
TABLE 203. France Tubeless Insulin Pumps Market Size, by Type Of Diabetes, 2017-2032 (USD Million)
TABLE 204. France Tubeless Insulin Pumps Market Size, by Connectivity, 2017-2032 (USD Million)
TABLE 205. France Tubeless Insulin Pumps Market Size, by Sensor Wear Duration, 2017-2032 (USD Million)
TABLE 206. France Tubeless Insulin Pumps Market Size, by Price Range, 2017-2032 (USD Million)
TABLE 207. France Tubeless Insulin Pumps Market Size, by Technology Generation, 2017-2032 (USD Million)
TABLE 208. France Tubeless Insulin Pumps Market Size, by End User, 2017-2032 (USD Million)
TABLE 209. France Tubeless Insulin Pumps Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 210. Russia Tubeless Insulin Pumps Market Size, 2017-2032 (USD Million)
TABLE 211. Russia Tubeless Insulin Pumps Market Size, by Type Of Diabetes, 2017-2032 (USD Million)
TABLE 212. Russia Tubeless Insulin Pumps Market Size, by Connectivity, 2017-2032 (USD Million)
TABLE 213. Russia Tubeless Insulin Pumps Market Size, by Sensor Wear Duration, 2017-2032 (USD Million)
TABLE 214. Russia Tubeless Insulin Pumps Market Size, by Price Range, 2017-2032 (USD Million)
TABLE 215. Russia Tubeless Insulin Pumps Market Size, by Technology Generation, 2017-2032 (USD Million)
TABLE 216. Russia Tubeless Insulin Pumps Market Size, by End User, 2017-2032 (USD Million)
TABLE 217. Russia Tubeless Insulin Pumps Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 218. Italy Tubeless Insulin Pumps Market Size, 2017-2032 (USD Million)
TABLE 219. Italy Tubeless Insulin Pumps Market Size, by Type Of Diabetes, 2017-2032 (USD Million)
TABLE 220. Italy Tubeless Insulin Pumps Market Size, by Connectivity, 2017-2032 (USD Million)
TABLE 221. Italy Tubeless Insulin Pumps Market Size, by Sensor Wear Duration, 2017-2032 (USD Million)
TABLE 222. Italy Tubeless Insulin Pumps Market Size, by Price Range, 2017-2032 (USD Million)
TABLE 223. Italy Tubeless Insulin Pumps Market Size, by Technology Generation, 2017-2032 (USD Million)
TABLE 224. Italy Tubeless Insulin Pumps Market Size, by End User, 2017-2032 (USD Million)
TABLE 225. Italy Tubeless Insulin Pumps Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 226. Spain Tubeless Insulin Pumps Market Size, 2017-2032 (USD Million)
TABLE 227. Spain Tubeless Insulin Pumps Market Size, by Type Of Diabetes, 2017-2032 (USD Million)
TABLE 228. Spain Tubeless Insulin Pumps Market Size, by Connectivity, 2017-2032 (USD Million)
TABLE 229. Spain Tubeless Insulin Pumps Market Size, by Sensor Wear Duration, 2017-2032 (USD Million)
TABLE 230. Spain Tubeless Insulin Pumps Market Size, by Price Range, 2017-2032 (USD Million)
TABLE 231. Spain Tubeless Insulin Pumps Market Size, by Technology Generation, 2017-2032 (USD Million)
TABLE 232. Spain Tubeless Insulin Pumps Market Size, by End User, 2017-2032 (USD Million)
TABLE 233. Spain Tubeless Insulin Pumps Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 234. China Tubeless Insulin Pumps Market Size, 2017-2032 (USD Million)
TABLE 235. China Tubeless Insulin Pumps Market Size, by Type Of Diabetes, 2017-2032 (USD Million)
TABLE 236. China Tubeless Insulin Pumps Market Size, by Connectivity, 2017-2032 (USD Million)
TABLE 237. China Tubeless Insulin Pumps Market Size, by Sensor Wear Duration, 2017-2032 (USD Million)
TABLE 238. China Tubeless Insulin Pumps Market Size, by Price Range, 2017-2032 (USD Million)
TABLE 239. China Tubeless Insulin Pumps Market Size, by Technology Generation, 2017-2032 (USD Million)
TABLE 240. China Tubeless Insulin Pumps Market Size, by End User, 2017-2032 (USD Million)
TABLE 241. China Tubeless Insulin Pumps Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 242. India Tubeless Insulin Pumps Market Size, 2017-2032 (USD Million)
TABLE 243. India Tubeless Insulin Pumps Market Size, by Type Of Diabetes, 2017-2032 (USD Million)
TABLE 244. India Tubeless Insulin Pumps Market Size, by Connectivity, 2017-2032 (USD Million)
TABLE 245. India Tubeless Insulin Pumps Market Size, by Sensor Wear Duration, 2017-2032 (USD Million)
TABLE 246. India Tubeless Insulin Pumps Market Size, by Price Range, 2017-2032 (USD Million)
TABLE 247. India Tubeless Insulin Pumps Market Size, by Technology Generation, 2017-2032 (USD Million)
TABLE 248. India Tubeless Insulin Pumps Market Size, by End User, 2017-2032 (USD Million)
TABLE 249. India Tubeless Insulin Pumps Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 250. Japan Tubeless Insulin Pumps Market Size, 2017-2032 (USD Million)
TABLE 251. Japan Tubeless Insulin Pumps Market Size, by Type Of Diabetes, 2017-2032 (USD Million)
TABLE 252. Japan Tubeless Insulin Pumps Market Size, by Connectivity, 2017-2032 (USD Million)
TABLE 253. Japan Tubeless Insulin Pumps Market Size, by Sensor Wear Duration, 2017-2032 (USD Million)
TABLE 254. Japan Tubeless Insulin Pumps Market Size, by Price Range, 2017-2032 (USD Million)
TABLE 255. Japan Tubeless Insulin Pumps Market Size, by Technology Generation, 2017-2032 (USD Million)
TABLE 256. Japan Tubeless Insulin Pumps Market Size, by End User, 2017-2032 (USD Million)
TABLE 257. Japan Tubeless Insulin Pumps Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 258. Australia Tubeless Insulin Pumps Market Size, 2017-2032 (USD Million)
TABLE 259. Australia Tubeless Insulin Pumps Market Size, by Type Of Diabetes, 2017-2032 (USD Million)
TABLE 260. Australia Tubeless Insulin Pumps Market Size, by Connectivity, 2017-2032 (USD Million)
TABLE 261. Australia Tubeless Insulin Pumps Market Size, by Sensor Wear Duration, 2017-2032 (USD Million)
TABLE 262. Australia Tubeless Insulin Pumps Market Size, by Price Range, 2017-2032 (USD Million)
TABLE 263. Australia Tubeless Insulin Pumps Market Size, by Technology Generation, 2017-2032 (USD Million)
TABLE 264. Australia Tubeless Insulin Pumps Market Size, by End User, 2017-2032 (USD Million)
TABLE 265. Australia Tubeless Insulin Pumps Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 266. South Korea Tubeless Insulin Pumps Market Size, 2017-2032 (USD Million)
TABLE 267. South Korea Tubeless Insulin Pumps Market Size, by Type Of Diabetes, 2017-2032 (USD Million)
TABLE 268. South Korea Tubeless Insulin Pumps Market Size, by Connectivity, 2017-2032 (USD Million)
TABLE 269. South Korea Tubeless Insulin Pumps Market Size, by Sensor Wear Duration, 2017-2032 (USD Million)
TABLE 270. South Korea Tubeless Insulin Pumps Market Size, by Price Range, 2017-2032 (USD Million)
TABLE 271. South Korea Tubeless Insulin Pumps Market Size, by Technology Generation, 2017-2032 (USD Million)
TABLE 272. South Korea Tubeless Insulin Pumps Market Size, by End User, 2017-2032 (USD Million)
TABLE 273. South Korea Tubeless Insulin Pumps Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 274. Global Tubeless Insulin Pumps Market Share, by Key Player, 2025
TABLE 275. Global Tubeless Insulin Pumps Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Advanced Microfluidics SA
  • APEX Medical Devices
  • Ascensia Diabetes Care
  • Beta Bionics, Inc.
  • Bigfoot Biomedical, Inc.
  • Cam Med LLC
  • CareMedi Co., Ltd.
  • Cellnovo Group plc
  • CeQur Corporation
  • Debiotech S.A.
  • Diabeloop SAS
  • EOFlow Co., Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Insulet Corporation
  • Johnson & Johnson
  • Luna Health Inc.
  • Medipacs Inc.
  • Medtrum Technologies Inc.
  • MicroPort Scientific Corporation
  • Modular Medical, Inc.
  • PharmaSens AG
  • Tandem Diabetes Care, Inc.
  • Terumo Corporation
  • Valeritas Holdings, Inc.
  • ViCentra B.V.
  • Ypsomed AG